Key Developments: Medinet Co Ltd (2370.T)

2370.T on Tokyo Stock Exchange

257JPY
8:55pm EST
Price Change (% chg)

¥-16 (-5.86%)
Prev Close
¥273
Open
¥265
Day's High
¥270
Day's Low
¥253
Volume
2,698,000
Avg. Vol
4,708,637
52-wk High
¥465
52-wk Low
¥193

Search Stocks

Latest Key Developments (Source: Significant Developments)

MEDINET Co Ltd signs license contract with Emo Biomedicine Corp.
Monday, 22 Dec 2014 01:00am EST 

MEDINET Co Ltd:Signed a license contract of approach of activation of antigen-presenting cell (EP1930414) with Emo Biomedicine Corp.  Full Article

MEDINET Co Ltd commences clinical trial
Thursday, 20 Nov 2014 10:00pm EST 

MEDINET Co Ltd:Says to commence clinical trial for cellular immunotherapies for refractory malignant tumor.  Full Article

MEDINET Co Ltd expects extraordinary loss for FY 2014
Thursday, 13 Nov 2014 03:00am EST 

MEDINET Co Ltd:Expected extraordinary loss of 580 mln yen for FY ended Sep. 2014 and says recorded as loss on provision of allowance for doubtful accounts.  Full Article

MEDINET Co Ltd changes president
Wednesday, 29 Oct 2014 04:45am EDT 

MEDINET Co Ltd:Announces Yoshiji Kimura, the chairman of the board of the company, to also serve as president, to succeed Hiroshi Igi, effective Oct. 29.  Full Article

MEDINET Co Ltd appoints president
Thursday, 28 Aug 2014 04:10am EDT 

MEDINET Co Ltd:Appoints Hiroshi Igi as new president to succeed Kunihiko Suzuki, effective Aug. 28.  Full Article

MEDINET Co Ltd announces trial results in pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
Wednesday, 20 Aug 2014 02:00am EDT 

MEDINET Co Ltd:Announced trial results in pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma, with The University Of Tokyo Hospital.One of eight participators was reputed as Complete Response, one as Partial Response and three as Stable Disease.  Full Article

MEDINET Co Ltd announces change of president
Thursday, 31 Jul 2014 03:15am EDT 

MEDINET Co Ltd:Appoints Hiroshi Igi as president to replace Kunihiko Suzuki.Effective Oct. 1.  Full Article

MEDINET Co Ltd lowers consolidated full-year outlook for FY 2014
Thursday, 31 Jul 2014 03:15am EDT 

MEDINET Co Ltd:Says the company lowered the consolidated full-year outlook for the FY ending Sep. 2014.Revenue forecast decreased to 1,800 million yen from 2,270 million yen.Operating profit forecast decreased to a loss of 1,430 million yen from a loss of 965 million yen.Ordinary profit forecast decreased to a loss of 1,460 million yen from a loss of 965 million yen.Net profit forecast decreased to a loss of 1,060 million yen from a loss of 975 million yen.Earnings per share decreased to a loss of 12.03 yen from a loss of 11.07 yen.Comments that cell processing number lower than expected and increased costs are the main reasons for the forecast.  Full Article

MEDINET Co Ltd receives patent in Korea and China
Monday, 28 Jul 2014 10:30pm EDT 

MEDINET Co Ltd:Received patent named Method for activation treatment of antigen-presenting cell, in Korea and China.Says already received patent named Method for activation treatment of antigen-presenting cell, in 11 European countries, Australia, Japan and U.S.  Full Article

MEDINET announces joint research with Osaka University
Tuesday, 3 Jun 2014 02:00am EDT 

MEDINET Co Ltd:To start joint research with Osaka University following launch of collaboration research program on May 19, for research in immunoregulation and quality management technology development for graft cell in regenerative and cell medicine area.  Full Article

Search Stocks